Review Article
Abnormal Brain Circuitry and Neurophysiology Demonstrated by Molecular Imaging Modalities in Schizophrenia
Ayden Jacob1*, Sharon Cohen2and Abass Alavi31Oxford Institute for Radiation Oncology; University of Oxford, UK
3Department of Nuclear Medicine, University of Pennsylvania, USA
- Corresponding Author:
- Ayden Jacob
Oxford Institute for Radiation Oncology
University of Oxford, UK
E-mail: aydenjacob@berkeley.edu
Received date: June 03, 2013; Accepted date: June 25, 2013; Published date: June 27, 2013
Citation: Jacob A, Cohen S, Alavi A (2013) Abnormal Brain Circuitry and Neurophysiology Demonstrated by Molecular Imaging Modalities in Schizophrenia. J Alzheimers Dis Parkinsonism 3: 114. doi: 10.4172/2161-0460.1000114
Copyright: © 2013 Jacob A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Schizophrenia is a major mental disorder characterized by functional impairment and the presentation,
persistence, and severity of symptoms. Characterized as a brain disorder, the etiology of schizophrenia remains elusive. Nevertheless, neuroimaging modalities have advanced the understanding of the neuroscientific community in regards to the structural and functional abnormalities inherent in the brains of schizophrenics. Neurochemical and molecular strategies are beginning to form a subtle consensus in the biomedical community as to the specificities of the disease on an organic level. Developing our understanding of the micro-abnormalities present in this disorder will allow the medical community to advance our neuropharmological approach to treating, curing, and perhaps preventing the onset of this disabling psychiatric disease.